US › Healthcare

Savara Inc (SVRA)

US · Healthcare · Biotechnology

$5.41+1.50%
Last close · 2026-08-04

Key statistics

Market cap
$1.12B
Forward P/E
0.4
P/B
6.36
Book value
$0.69
EPS (TTM)
$-0.56
52-week high
$7.00
52-week low
$2.43
50-day MA
$5.55
200-day MA
$5.41
Beta
0.24

Analyst view

Analysts rate Savara Inc a buy (6 buy, 2 hold, 0 sell out of 8) with an average price target of $10.94.

Shareholding

Insiders
2.59%
Institutions
104.61%

Largest institutional holders

FundStake
NEA Management Company, LLC11.94%
Bain Capital Life Sciences Investors, LLC8.59%
VR Adviser, LLC6.71%
Deerfield Management Co6.62%
TCG Crossover Management, LLC6.03%
BlackRock Inc5.51%
Frazier Life Sciences Management, L.P.4.74%
Polar Capital Holdings PLC4.66%

See the full picture

Technicals, trade setups with a published hit rate, $AI analysis and earnings-call summaries for Savara Inc — free to start.

Google PlayApp Store

Other Healthcare companies

Eli Lilly and CompanyJohnson & JohnsonAbbVie IncUnitedHealth Group IncorporatedMerck & Company IncNovartis AG ADRAstraZeneca PLCThermo Fisher Scientific IncNovo Nordisk A/SAmgen IncAbbott LaboratoriesGilead Sciences Inc

Data updated 2026-08-05.